---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-006060"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:34:44.909702+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Panacea exchanges 350 Series A shares for $385K convertible note & warrants

## Summary
- Issued $385K 10% OID senior convertible note due March 2023, convertible at $1.40/sh.
- Issued five-year warrants to purchase 275,000 shares at $1.40/sh, exercisable from May 18, 2022.
- Note and warrants issued in exchange for 350 shares of 0% Series A Convertible Preferred Stock under MFN rights.
- Note has 18% default interest, 125% redemption premium, and conversion adjustments including Qualified Offering.
- Registration rights agreement subordinated to prior November 2021 private placement investor's rights.

## SEC filing metadata
- accession: 0001493152-22-006060
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315222006060/0001493152-22-006060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315222006060/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-006060
- JSON: https://secwatch.observer/filing/0001493152-22-006060.json
- Plain text: https://secwatch.observer/filing/0001493152-22-006060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.